WO1998004702A3 - Proteines, notamment proteines membranaires, d'helicobacter pylori, leur preparation et utilisation - Google Patents
Proteines, notamment proteines membranaires, d'helicobacter pylori, leur preparation et utilisation Download PDFInfo
- Publication number
- WO1998004702A3 WO1998004702A3 PCT/IB1997/000981 IB9700981W WO9804702A3 WO 1998004702 A3 WO1998004702 A3 WO 1998004702A3 IB 9700981 W IB9700981 W IB 9700981W WO 9804702 A3 WO9804702 A3 WO 9804702A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- proteins
- preparation
- helicobacter pylori
- particular membrane
- seq
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 241000590002 Helicobacter pylori Species 0.000 title abstract 2
- 108010052285 Membrane Proteins Proteins 0.000 title abstract 2
- 229940037467 helicobacter pylori Drugs 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002259924A CA2259924A1 (fr) | 1996-07-26 | 1997-07-25 | Proteines, notamment proteines membranaires, d'helicobacter pylori, leur preparation et utilisation |
EP97932967A EP0918864A2 (fr) | 1996-07-26 | 1997-07-25 | Proteines, notamment proteines membranaires, d'helicobacter pylori, leur preparation et utilisation |
JP10508651A JP2001502886A (ja) | 1996-07-26 | 1997-07-25 | Helicobacter pyloriのタンパク質、特に膜タンパク質、それらの調製および使用 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19630390.7 | 1996-07-26 | ||
DE19630390A DE19630390A1 (de) | 1996-07-26 | 1996-07-26 | Proteine, insbesondere Membranproteine von Helicobacter pylori, ihre Herstellung und Verwendung |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/662,126 Continuation US20050063987A1 (en) | 1996-07-26 | 2003-09-12 | Proteins, in particular membrane proteins, of Helicobacter pylori, their preparation and use |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998004702A2 WO1998004702A2 (fr) | 1998-02-05 |
WO1998004702A3 true WO1998004702A3 (fr) | 1998-04-23 |
Family
ID=7801051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB1997/000981 WO1998004702A2 (fr) | 1996-07-26 | 1997-07-25 | Proteines, notamment proteines membranaires, d'helicobacter pylori, leur preparation et utilisation |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0918864A2 (fr) |
JP (1) | JP2001502886A (fr) |
CA (1) | CA2259924A1 (fr) |
DE (1) | DE19630390A1 (fr) |
WO (1) | WO1998004702A2 (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2324093A (en) | 1996-01-04 | 1998-10-14 | Rican Limited | Helicobacter pylori bacterioferritin |
DE19847628C2 (de) * | 1998-10-15 | 2000-10-19 | Chiron Behring Gmbh & Co | Helicobacter pylori-Impfstoff |
AUPQ347199A0 (en) * | 1999-10-15 | 1999-11-11 | Csl Limited | Novel polypeptide fragments |
EP2275129A3 (fr) | 2000-01-17 | 2013-11-06 | Novartis Vaccines and Diagnostics S.r.l. | Vaccin omv complèté contre la méningocoque |
MX357775B (es) | 2000-10-27 | 2018-07-20 | J Craig Venter Inst Inc | Acidos nucleicos y proteinas de los grupos a y b de estreptococos. |
GB0107658D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Streptococcus pneumoniae |
GB0107661D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Staphylococcus aureus |
EP1399183B1 (fr) | 2001-05-31 | 2010-06-30 | Novartis Vaccines and Diagnostics, Inc. | Particules de replicon d'alphavirus chimerique |
GB0115176D0 (en) | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
GB0118249D0 (en) | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
GB0121591D0 (en) | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
ATE406912T1 (de) | 2001-12-12 | 2008-09-15 | Novartis Vaccines & Diagnostic | Immunisierung gegen chlamydia tracheomatis |
US7501134B2 (en) | 2002-02-20 | 2009-03-10 | Novartis Vaccines And Diagnostics, Inc. | Microparticles with adsorbed polypeptide-containing molecules |
GB0220194D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
LT2395073T (lt) | 2002-11-01 | 2017-11-10 | Glaxosmithkline Biologicals S.A. | Džiovinimo būdas |
AU2003288660A1 (en) | 2002-11-15 | 2004-06-15 | Chiron Srl | Unexpected surface proteins in neisseria meningitidis |
GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
EP1585542B1 (fr) | 2002-12-27 | 2012-06-13 | Novartis Vaccines and Diagnostics, Inc. | Immunogènes contenant des compositions de phospholipide |
EP1608369B1 (fr) | 2003-03-28 | 2013-06-26 | Novartis Vaccines and Diagnostics, Inc. | Utilisation de composés organiques pour l'immunopotentialisation |
GB0308198D0 (en) | 2003-04-09 | 2003-05-14 | Chiron Srl | ADP-ribosylating bacterial toxin |
ATE437633T2 (de) | 2003-06-02 | 2009-08-15 | Novartis Vaccines & Diagnostic | Immunogene zusammensetzungen auf basis von biologisch abbaubaren mikroteilchen enthaltend ein diphtherie- und ein tetanustoxoid |
JP2008504292A (ja) | 2004-06-24 | 2008-02-14 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド | 免疫増強用の化合物 |
US20110104186A1 (en) | 2004-06-24 | 2011-05-05 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
US20060165716A1 (en) | 2004-07-29 | 2006-07-27 | Telford John L | Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae |
US20110223197A1 (en) | 2005-10-18 | 2011-09-15 | Novartis Vaccines And Diagnostics Inc. | Mucosal and Systemic Immunization with Alphavirus Replicon Particles |
JP5215865B2 (ja) | 2005-11-22 | 2013-06-19 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド | ノロウイルス抗原およびサポウイルス抗原 |
CA2646539A1 (fr) | 2006-03-23 | 2007-09-27 | Novartis Ag | Composes d'imidazoquinoxaline utilises en tant qu'immunomodulateurs |
GB0700562D0 (en) | 2007-01-11 | 2007-02-21 | Novartis Vaccines & Diagnostic | Modified Saccharides |
AU2008299376B2 (en) | 2007-09-12 | 2013-02-28 | Glaxosmithkline Biologicals S.A. | GAS57 mutant antigens and GAS57 antibodies |
KR101773114B1 (ko) | 2007-12-21 | 2017-08-30 | 노파르티스 아게 | 스트렙토라이신 o의 돌연변이 형태 |
AU2010204139A1 (en) | 2009-01-12 | 2011-08-11 | Novartis Ag | Cna_B domain antigens in vaccines against gram positive bacteria |
WO2011149564A1 (fr) | 2010-05-28 | 2011-12-01 | Tetris Online, Inc. | Infrastructure de jeu informatique asynchrone hybride interactif |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994026901A1 (fr) * | 1993-05-19 | 1994-11-24 | Institut Pasteur | Compositions immunogenes destinees a proteger contre les infections a helicobacter, polypeptides utilises dans lesdites compositions et sequences d'acides nucleiques codant lesdits polypeptides |
FR2724936A1 (fr) * | 1994-09-22 | 1996-03-29 | Pasteur Merieux Serums Vacc | Recepteur lactoferrine d'helicobacter |
WO1997012908A1 (fr) * | 1995-10-04 | 1997-04-10 | Pasteur Merieux Serums & Vaccins | NOUVELLE PROTEINE MEMBRANAIRE p76 D'HELICOBACTER PYLORI |
WO1997012909A1 (fr) * | 1995-10-04 | 1997-04-10 | Pasteur Merieux Serums & Vaccins | Nouvelles proteines membranaires d'helicobacter pylori |
-
1996
- 1996-07-26 DE DE19630390A patent/DE19630390A1/de not_active Withdrawn
-
1997
- 1997-07-25 CA CA002259924A patent/CA2259924A1/fr not_active Abandoned
- 1997-07-25 WO PCT/IB1997/000981 patent/WO1998004702A2/fr not_active Application Discontinuation
- 1997-07-25 EP EP97932967A patent/EP0918864A2/fr not_active Withdrawn
- 1997-07-25 JP JP10508651A patent/JP2001502886A/ja not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994026901A1 (fr) * | 1993-05-19 | 1994-11-24 | Institut Pasteur | Compositions immunogenes destinees a proteger contre les infections a helicobacter, polypeptides utilises dans lesdites compositions et sequences d'acides nucleiques codant lesdits polypeptides |
FR2724936A1 (fr) * | 1994-09-22 | 1996-03-29 | Pasteur Merieux Serums Vacc | Recepteur lactoferrine d'helicobacter |
WO1997012908A1 (fr) * | 1995-10-04 | 1997-04-10 | Pasteur Merieux Serums & Vaccins | NOUVELLE PROTEINE MEMBRANAIRE p76 D'HELICOBACTER PYLORI |
WO1997012909A1 (fr) * | 1995-10-04 | 1997-04-10 | Pasteur Merieux Serums & Vaccins | Nouvelles proteines membranaires d'helicobacter pylori |
Non-Patent Citations (9)
Title |
---|
DOIG P ET AL: "IDENTIFICATION OF SURFACE-EXPOSED OUTER MEMBRANE ANTIGENS OF HELICOBACTER PYLORI", INFECTION AND IMMUNITY, vol. 62, no. 10, October 1994 (1994-10-01), pages 4526 - 4533, XP002003746 * |
DOIG P ET AL: "ISOLATION AND CHARACTERIZATION OF A CONSERVED PORIN PROTEIN FROM HELICOBACTER PYLORI", JOURNAL OF BACTERIOLOGY, vol. 177, no. 19, 1 October 1995 (1995-10-01), pages 5447 - 5452, XP000570478 * |
DOIG P ET AL: "PRODUCTION OF A CONSERVED ADHESIN BY THE HUMAN GASTRODUODENAL PATHOGEN HELICOBACTER PYLORI", JOURNAL OF BACTERIOLOGY, vol. 174, no. 8, April 1992 (1992-04-01), pages 2539 - 2547, XP000601442 * |
DUNN B E ET AL: "PURIFICATION AND CHARACTERIZATION OF UREASE FROM HELICOBACTER PYLORI", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 265, no. 16, 5 June 1990 (1990-06-05), pages 9464 - 9469, XP000568708 * |
EVANS D G ET AL: "CLONING, NUCLEOTIDE SEQUENCE, AND EXPRESSION OF A GENE ENCODING AN ADHESIN SUBUNIT PROTEIN OF HELICOBACTER PYLORI", JOURNAL OF BACTERIOLOGY, vol. 175, no. 3, February 1993 (1993-02-01), pages 674 - 683, XP000601419 * |
EXNER M M ET AL: "ISOLATION AND CHARACTERIZATION OF A FAMILY OF PORIN PROTEINS FROM HELICOBACTER PYLORI", INFECTION AND IMMUNITY, vol. 63, no. 4, 1 April 1995 (1995-04-01), pages 1567 - 1572, XP002003585 * |
M.J. BLASER ET AL.: "Identification and characterization of Campylobacter jejuni outer membrane proteins", INFECTION AND IMMUNITY, vol. 42, no. 1, October 1983 (1983-10-01), ASM,WASHINGTON,DC,US, pages 276 - 284, XP002047821 * |
TUFANO M A ET AL: "IMMUNOBIOLOGICAL ACTIVITIES OF HELICOBACTER PYLORY PORINS", INFECTION AND IMMUNITY, vol. 62, no. 4, April 1994 (1994-04-01), pages 1392 - 1399, XP002003747 * |
WORST D J ET AL: "IRON-REPRESSIBLE OUTER MEMBRANE PROTEINS OF HELICOBACTER PYLORI INVOLVED IN HEME UPTAKE", INFECTION AND IMMUNITY, vol. 63, no. 10, October 1995 (1995-10-01), pages 4161 - 4165, XP000675337 * |
Also Published As
Publication number | Publication date |
---|---|
WO1998004702A2 (fr) | 1998-02-05 |
DE19630390A1 (de) | 1998-01-29 |
EP0918864A2 (fr) | 1999-06-02 |
CA2259924A1 (fr) | 1998-02-05 |
JP2001502886A (ja) | 2001-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998004702A3 (fr) | Proteines, notamment proteines membranaires, d'helicobacter pylori, leur preparation et utilisation | |
EP1484339A3 (fr) | Protéines de "Domaine de Kunitz" a actvité antikallikreine et acides nucléiques les codant | |
BG102983A (en) | Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application | |
CA2102208A1 (fr) | Domaines de liaison dans les proteines notch et delta | |
WO1995001442A3 (fr) | Sequences de nucleotides et sequences d'acides amines du gene d'enveloppe 1 de 51 isolats du virus de l'hepatite c et utilisation de reactifs derives desdites sequences en tant que reactifs de diagnostic et vaccins | |
CA2269111A1 (fr) | Genes codant pour les facteurs de transcription des plantes | |
WO2002016418A3 (fr) | Peptide ou polypeptide capable de liaison avec l'inhibiteur de la proteine de l'apoptose | |
WO2002008426A3 (fr) | Proteine | |
WO2002072616A3 (fr) | Complexes de transfection | |
WO1996003506A3 (fr) | Analogue d'haemophilus hin47 a activite protease reduite | |
CA2281206A1 (fr) | Genes de geranyl diphosphate synthase | |
EP1006126A3 (fr) | Peptide possedant une activité ostéogénique | |
NZ296561A (en) | Adjuvant for attachment to molecule to improve activity, complex, preparation, nucleotide sequence and vaccine | |
NZ332565A (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof | |
AU3850997A (en) | Immunologically active proteins of borrelia burgdorferi, coded nuclein acids of such and their use in test kits and vaccines | |
AU1239997A (en) | Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes | |
CA2209298A1 (fr) | Analogues de ligand mpl | |
AU5776799A (en) | Modified hcv peptide vaccines | |
CA2253006A1 (fr) | Gene hydroxylase de beta-carotene | |
AU2001248822A1 (en) | Gd3-mimetic peptides | |
WO1995013386A3 (fr) | Enzyme de fusion de la proteine activatrice de la tyrosinase | |
WO1999051188A3 (fr) | Polypeptide comprenant l'acide amine d'un produit tronque de la proteine a n-terminale fixant la choline, vaccin derive de ce polypeptide et ses utilisations | |
GB2357507A (en) | Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants | |
WO2002038607A3 (fr) | Recepteur | |
DE60036676D1 (de) | G-protein-gekoppelter rezeptor-ähnliche proteine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2259924 Country of ref document: CA Ref country code: CA Ref document number: 2259924 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09230158 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997932967 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1997932967 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997932967 Country of ref document: EP |